Establishment Labs Holdings Inc. (ESTA)
NASDAQ
Closed
Oct 20, 2026
Day's Range
58.3952 wk Range
47.00Overview - ESTA - Establishment Labs Holdings Inc.
Key Statistics
Valuation
Enterprise Value
1.95B
P/E (Trailing)
‪-34.30‬
P/E (Forward)
‪986.33‬
PEG Ratio
‪1.08‬
Price / Sales (TTM)
‪7.17‬
Price / Book
‪81.62‬
EV / EBITDA
‪-217.74‬
Profitability
Gross Margin
‪70.63%‬
Profit Margin
‪-15.82%‬
Operating Margin
‪-6.35%‬
Return on Assets
‪-3.44%‬
Return on Equity
‪-175.30%‬
Ownership
Shares Outstanding
29.79M
Float
19.53M
Short % of Shares Outstanding
‪16.70%‬
Held by Insiders
‪10.04%‬
Held by Institutions
‪105.47%‬
Price stats
Beta
‪1.05‬
50-Day Avg
‪69.36‬
200-Day Avg
‪72.61‬
Analyst Consensus
10 analysts
Average price target
‪$ 102.44‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ESTA - Establishment Labs Holdings Inc.
Peers - ESTA - Establishment Labs Holdings Inc.
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
Profile Summary - ESTA - Establishment Labs Holdings Inc.
About
Establishment Labs Holdings Inc. is a medical technology company focused on breast aesthetics and reconstructive plastic surgery. Its core portfolio includes silicone gel-filled breast implants under the Motiva Implants brand, along with breast tissue expanders and related surgical technologies used in augmentation…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
